Robert M. Centor, MD; Dimitri M. Drekonja, MD, MS
Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Drekonja has disclosed no conflicts of interest.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Audio. Annals On Call - Fecal Transplantation for C difficile: Dr. Centor discusses the treatment of recurrent C difficile infection with Dr. Dimitri Drekonja.
Other Audio Options: Download MP3
Centor RM, Drekonja DM. Annals On Call - Fecal Transplantation for C difficile. Ann Intern Med. 2020;172:OC1. doi: https://doi.org/10.7326/A19-0022
Download citation file:
Published: Ann Intern Med. 2020;172(2):OC1.
Healthcare Delivery and Policy, Hospital Medicine, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use